Thomas Harding Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Thomas Harding General Information

Biography

Mr. Thomas Harding serves as Partner at Bridford Group. He serves as a Board Member at LenioBio, Penfold and Touchlight. He also served as Board Member at DAZN Group. He works with Jörg Mohaupt on media/online and telecoms investments at Access Industries. He previously worked on TMT investments at Access Industries, after joining from Weil, Gotshal and Manges' private equity department. He previously headed-up Access's European legal function, after joining from Weil, Gotshal and Manges. He has an MA from the University of Cambridge and subsequently studied at City University (law) and London Business School (finance). He is also a director of AINMT Holdings AB, Channel 10 TV, Grabyo Limited, Solar Foods Oy, Penfold Technology Limited,Ice Group ASA, Perform Group/DAZN, Channel 10 TV and Westwing Group GmbH, as well as being an officer of Access Industries, Inc. and a trustee of The Blavatnik School of Government Foundation at the University of Oxford.

Contact Information

Primary Position
Partner, Bridford Group
Education
College of Law, Degree
University of Cambridge, MA (Master of Arts)
University of Cambridge, BA (Bachelor of Arts)
Gender
Male
Email
th
Address
  • 6 Arlington Street
  • Saint James's
  • London SW1A 1RE
  • England, United Kingdom

Thomas Harding Positions (1)

Firm name Firm type Title Location Industry Since
Bridford Group Investor Partner London, United Kingdom Venture Capital

Thomas Harding Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
LenioBio Drug Discovery Privately Held (backing) Venture Capital-Backed Dusseldorf, Germany
Penfold Financial Software Privately Held (backing) Venture Capital-Backed London, United Kingdom
Touchlight Drug Discovery Privately Held (backing) Venture Capital-Backed Hampton, United Kingdom

Thomas Harding Lead Partner on Deals (3)

Thomas Harding has been the lead partner on 3 deals. Their latest deal was with Penfold, a financial software company. The deal was made for on 05-Aug-2022.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Penfold 05-Aug-2022 Early Stage VC (Series A) Completed Financial Software London, United Kingdom
LenioBio 07-Mar-2022 Completed Drug Discovery Dusseldorf, Germany
Touchlight 15-Sep-2021 Completed Drug Discovery Hampton, United Kingdom

Thomas Harding Network (51)

Board Members (23)

Name Company Representing Location From
JD Fouchard Ainmt Ainmt Oslo, Norway
Karen Fallen LenioBio Self Dusseldorf, Germany
Touchlight Self Hampton, United Kingdom
Ainmt Ainmt Oslo, Norway
Touchlight Touchlight Hampton, United Kingdom

Portfolio Executives (28)

Name Company Role Deal date Location
Stuart Robinson Penfold Co-founder, Chief Technology Officer & Board Member 05-Aug-2022 London, United Kingdom
Gemma Happe Penfold Chief Operating Officer 05-Aug-2022 London, United Kingdom
Penfold Co-Founder, Chief Executive Officer & Board Member 05-Aug-2022 London, United Kingdom
LenioBio Chief Scientific Officer 07-Mar-2022 Dusseldorf, Germany
LenioBio Co-Founder 07-Mar-2022 Dusseldorf, Germany

Thomas Harding FAQs

  • Who is Thomas Harding?

    Mr. Thomas Harding serves as Partner at Bridford Group.

  • How much does Thomas Harding typically invest?

    Thomas Harding's median deal size is .

  • What is Thomas Harding’s main position?

    Thomas Harding’s primary position is Partner.

  • How many active board seats does Thomas Harding hold?

    Thomas Harding holds 3 board seats including LenioBio, Penfold, and Touchlight.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »